Topographical variations in the skin barrier and their role in disease pathogenesis

Documenti analoghi

• Beremagene geperpavec (B‐ VEC ) for infantile dystrophic epidermolysis bullosa: Benefit of early intervention
  di: Meropi Karakioulaki, et al.
  Pubblicazione: (2025)
• Experience of patients and healthcare practitioners with interdisciplinary care in immune‐mediated inflammatory diseases with skin manifestations: A systematic scoping review
  di: Ellen Van den Steen, et al.
  Pubblicazione: (2024)
• IL‐6 levels dominate the serum cytokine signature of severe epidermolysis bullosa: A prospective cohort study
  di: A. Reimer‐Taschenbrecker, et al.
  Pubblicazione: (2024)
• Systemic anti‐inflammatory therapy in congenital ichthyosis: Real‐world experience in a series of 22 cases
  di: Laura Katharina Trefzer, et al.
  Pubblicazione: (2024)
• Darier disease: Current insights and challenges in pathogenesis and management
  di: Monika Ettinger, et al.
  Pubblicazione: (2024)